Merlin Labs common stock is in a death spiral toward zero because preferred holders and shorts hold the upper hand. Equity raises have no limit and the preferred ranks senior to the common, so fundamental analysis does not matter. @ShawarmaCapital, a former bull, attributes the fall from $17 to $1.81 to a roughly 44M-share unlock on a thin float, a Series A Preferred conversion reset on October 15 already headed for its $5 floor, and an unwinding short squeeze. x.com x.com

